Novel Brain Penetrant For Treating X-ALD Among Raft Of New EU Filings

 
• By Neena Brizmohun

Investigational products from Minoryx and a host of other companies targeting a range of diseases are now under review by the European Medicines Agency for potential EU approval.

Wooden blocks with the word Review. Customer review concept. Reviewing, auditing, reviewer. Service rating. Feedback.
The EMA has started reviewing a new batch of drug market applications • Source: Alamy

More from Europe

More from Geography